NDC properties for NDC 9 0051-8462
NDC item 00051846212
NDC 9 | 0051-8462 |
---|---|
NDC 10 | 0051-8462-12 |
NDC Item | 00051846212 |
packaging | 1.25 g in 1 PACKET |
DCSA | CIII |
FDA SPL set id | 697433 |
Labeler | AbbVie Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2025-05-01 |
Marketing effective time low | 2011-04-29 |
Marketing status | COMPLETED |
NDA | NDA022309 |
NDC item 00051846231
NDC 9 | 0051-8462 |
---|---|
NDC 10 | 0051-8462-31 |
NDC Item | 00051846231 |
packaging | 30 PACKET in 1 CARTON (0051-8462-31) / 1.25 g in 1 PACKET (0051-8462-12) |
DCSA | CIII |
FDA SPL set id | 697433 |
Labeler | AbbVie Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2025-05-01 |
Marketing effective time low | 2011-04-29 |
Marketing status | COMPLETED |
NDA | NDA022309 |
NDC item 17139056212
NDC 9 | 17139-562 |
---|---|
NDC 10 | 17139-562-12 |
NDC Item | 17139056212 |
packaging | 1.25 g in 1 PACKET |
DCSA | CIII |
FDA SPL set id | 810696 |
Labeler | ASCEND Therapeutics U.S., LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2023-02-17 |
Marketing status | ACTIVE |
NDA | NDA022309 |